Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Olema Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 66 | 87 | +21 |
| Shares | 33.4M | 36.4M | +3.00M (+9.0%) |
| Value | $116.1M | $329.2M | +$213.1M (+183.5%) |
New holders (35)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (14)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Janus Henderson Group PLC | 2,085,179 | $7.28M |
| Laurion Capital Management LP | 513,972 | $1.78M |
| Walleye Capital LLC | 182,337 | $632.7K |
| Man Group plc | – | $124.3K |
| Marshall Wace, LLP | 35,700 | $123.9K |
| Squarepoint Ops LLC | 23,943 | $83.1K |
| HRT Financial LP | 19,644 | $68.0K |
| Prelude Capital Management, LLC | 16,225 | $56.3K |
| Cubist Systematic Strategies, LLC | 15,161 | $52.6K |
| Tudor Investment Corp Et Al | 12,745 | $44.0K |
| HSBC Holdings PLC | 10,150 | $37.1K |
| PDT Partners, LLC | 10,573 | $36.7K |
| Virtu Financial LLC | 10,015 | $35.0K |
| Crewe Advisors LLC | 314 | $1.09K |